Terms: = Breast cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
603 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-src kinase inhibitors with prominent antitumor activity.
Awaji AA; Zaloa WAZE; Seleem MA; Alswah M; Elsebaei MM; Bayoumi AH; El-Morsy AM; Alfaifi MY; Shati AA; Elbehairi SEI; Almaghrabi M; Aljohani AKB; Ahmed HEA
Bioorg Chem; 2024 Apr; 145():107228. PubMed ID: 38422592
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer.
Zou H; Luo J; Guo Y; Deng L; Zeng L; Pan Y; Li P
Drug Resist Updat; 2024 Mar; 73():101051. PubMed ID: 38219531
[TBL] [Abstract] [Full Text] [Related]
4. Design and synthesis of dual BRD4/src inhibitors for treatment of triple-negative breast cancer.
Wang Y; Huang A; Chen L; Sun F; Zhao M; Zhang M; Xie Y; Xu S; Li M; Hong L; Li G; Wang R
Eur J Med Chem; 2024 Jan; 264():116009. PubMed ID: 38070430
[TBL] [Abstract] [Full Text] [Related]
5. Metabolomic Rewiring Promotes Endocrine Therapy Resistance in breast cancer.
Ahn S; Park JH; Grimm SL; Piyarathna DWB; Samanta T; Putluri V; Mezquita D; Fuqua SAW; Putluri N; Coarfa C; Kaipparettu BA
Cancer Res; 2024 Jan; 84(2):291-304. PubMed ID: 37906431
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells.
Yang MH; Sethi G; Ravish A; Mohan AK; Pandey V; Lobie PE; Basappa S; Basappa B; Ahn KS
Chem Biol Interact; 2023 Dec; 386():110780. PubMed ID: 37879592
[TBL] [Abstract] [Full Text] [Related]
7. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor antagonist peptides inhibit tumor growth and metastasis in breast cancer through repression of c-src and STAT3 genes.
Bejari M; Sasani ST; Asghari SM; Kolshan MN
Mol Biol Rep; 2023 Nov; 50(11):9213-9219. PubMed ID: 37789224
[TBL] [Abstract] [Full Text] [Related]
9. AIB1/src-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Kiliti AJ; Sharif GM; Martin MB; Wellstein A; Riegel AT
Front Endocrinol (Lausanne); 2023; 14():1250218. PubMed ID: 37711895
[TBL] [Abstract] [Full Text] [Related]
10. Suppressing src-Mediated EGFR Signaling by Sustained Calcium Supply Targeting Triple-Negative breast cancer.
Jeong KY; Park SY; Park MH; Kim HM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686097
[TBL] [Abstract] [Full Text] [Related]
11. Claudin-10 in the Blood Brain Barrier Function of Cerebral Endothelial Cells and Transendothelial Invasion of breast cancer Cells.
Zhuang X; Ji W; Fang Z; Yang Y; Ruge F; Dou QP; Li X; Xu B; Jiang WG; Martin TA
Anticancer Res; 2023 Sep; 43(9):3923-3934. PubMed ID: 37648330
[TBL] [Abstract] [Full Text] [Related]
12. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
[TBL] [Abstract] [Full Text] [Related]
13. Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development.
Dai H; Xu W; Wang L; Li X; Sheng X; Zhu L; Li Y; Dong X; Zhou W; Han C; Mao Y; Yao L
Breast Cancer Res; 2023 Jul; 25(1):90. PubMed ID: 37507768
[TBL] [Abstract] [Full Text] [Related]
14. Ponatinib: An update on its drug targets, therapeutic potential and safety.
Gao Y; Ding Y; Tai XR; Zhang C; Wang D
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188949. PubMed ID: 37399979
[TBL] [Abstract] [Full Text] [Related]
15. Casein kinase 1 controls the shuttling of epidermal growth factor receptor and estrogen receptor in endometrial carcinoma induced by breast cancer hormonal therapy: Relevance of GPER1/src.
Hoang LN; Lee SJ
Cell Signal; 2023 Aug; 108():110733. PubMed ID: 37257767
[TBL] [Abstract] [Full Text] [Related]
16. P2Y
Jin H; Ko YS; Yun SP; Park SW; Kim HJ
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37165911
[TBL] [Abstract] [Full Text] [Related]
17. CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src/FAK and promotes TNBC progression.
Luo P; Gong Y; Weng J; Wen F; Luo J; Hu C; Xiao J; Shu J
Cell Signal; 2023 Aug; 108():110690. PubMed ID: 37121557
[TBL] [Abstract] [Full Text] [Related]
18. An Ethanol Extract of
Jeong JH; Park HJ; Chi GY; Choi YH; Park SH
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110648
[TBL] [Abstract] [Full Text] [Related]
19. The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis.
Lv Y; Mou Y; Su J; Liu S; Ding X; Yuan Y; Li G; Li G
Sci Rep; 2023 Mar; 13(1):3816. PubMed ID: 36882618
[TBL] [Abstract] [Full Text] [Related]
20. A reversible src-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF
Ruiz-Saenz A; Atreya CE; Wang C; Pan B; Dreyer CA; Brunen D; Prahallad A; Muñoz DP; Ramms DJ; Burghi V; Spassov DS; Fewings E; Hwang YC; Cowdrey C; Moelders C; Schwarzer C; Wolf DM; Hann B; VandenBerg SR; Shokat K; Moasser MM; Bernards R; Gutkind JS; van 't Veer LJ; Coppé JP
Nat Cancer; 2023 Feb; 4(2):240-256. PubMed ID: 36759733
[TBL] [Abstract] [Full Text] [Related]
[Next]
